For: | Chen YP, Yang JS, Liu DT, Yang WP. Long-term effects of proglumide on resection of cardiac adenocarcinoma. World J Gastroenterol 2005; 11(17): 2549-2551 [PMID: 15849809 DOI: 10.3748/wjg.v11.i17.2549] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i17/2549.htm |
Number | Citing Articles |
1 |
Beáta Pelles-Taskó, Angelika Varga, Krisztina Géresi, Béla Juhász, Zoltán Szilvássy, Ilona Benkő. CCK-1R-selective and non-selective cholecystokinin antagonists, lorglumide, and proglumide increased toxicity of carboplatin to granulocyte–macrophage progenitor cells (CFU-GM) of bone marrow of rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04391-6
|
2 |
Rafael Diaz-Nieto, Rafael Orti-Rodríguez, Marc Winslet. Post-surgical chemotherapy versus surgery alone for resectable gastric cancer. Cochrane Database of Systematic Reviews 2013; 2013(9) doi: 10.1002/14651858.CD008415.pub2
|
3 |
Jill P. Smith, Timothy K. Cooper, Christopher O. McGovern, Evan L. Gilius, Qing Zhong, Jiangang Liao, Alfredo A. Molinolo, J. Silvio Gutkind, Gail L. Matters. Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice. Pancreas 2014; 43(7): 1050 doi: 10.1097/MPA.0000000000000194
|